SurModics
Eden Prairie
About SurModics
SurModics provides surface modification and in vitro diagnostic technologies to the healthcare industry. It also develops and commercializes highly differentiated vascular intervention medical devices designed to address unmet clinical needs and engineered to the most demanding requirements. This key growth strategy leverages the combination of the company’s expertise in proprietary surface modification and drug-delivery coating technologies, along with its device design, development, and manufacturing capabilities.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $100K – $500K
- Total funding: $125.0M
- Funding stage: M&A
- Last round: Post-IPO Debt (Oct 2022)
- Ticker: nasdaq:SRDX
- Website: surmodics.com
- Phone: 9528292743
Industries & Categories
Biotechnology, Chemical, Health Care, Manufacturing, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/surmodics-46685 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.